- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-octamer
- Ligands
- 8 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 40 x SO4: SULFATE ION(Non-functional Binders)
- SO4.2: 2 residues within 4Å:- Chain A: R.347, Q.351
 Ligand excluded by PLIP- SO4.6: 4 residues within 4Å:- Chain A: Q.316, G.413, N.414, N.415
 Ligand excluded by PLIP- SO4.7: 5 residues within 4Å:- Chain A: W.231, R.242, L.286, S.287, V.288
 Ligand excluded by PLIP- SO4.9: 5 residues within 4Å:- Chain A: K.323, Y.420, R.515
- Chain H: R.509
- Ligands: SO4.10
 Ligand excluded by PLIP- SO4.10: 5 residues within 4Å:- Chain A: L.514, R.515, Q.518
- Chain H: R.509
- Ligands: SO4.9
 Ligand excluded by PLIP- SO4.20: 2 residues within 4Å:- Chain B: R.347, Q.351
 Ligand excluded by PLIP- SO4.24: 4 residues within 4Å:- Chain B: Q.316, G.413, N.414, N.415
 Ligand excluded by PLIP- SO4.25: 5 residues within 4Å:- Chain B: W.231, R.242, L.286, S.287, V.288
 Ligand excluded by PLIP- SO4.27: 5 residues within 4Å:- Chain B: K.323, Y.420, R.515
- Chain F: R.509
- Ligands: SO4.28
 Ligand excluded by PLIP- SO4.28: 5 residues within 4Å:- Chain B: L.514, R.515, Q.518
- Chain F: R.509
- Ligands: SO4.27
 Ligand excluded by PLIP- SO4.38: 2 residues within 4Å:- Chain C: R.347, Q.351
 Ligand excluded by PLIP- SO4.42: 4 residues within 4Å:- Chain C: Q.316, G.413, N.414, N.415
 Ligand excluded by PLIP- SO4.43: 5 residues within 4Å:- Chain C: W.231, R.242, L.286, S.287, V.288
 Ligand excluded by PLIP- SO4.45: 5 residues within 4Å:- Chain C: K.323, Y.420, R.515
- Chain E: R.509
- Ligands: SO4.46
 Ligand excluded by PLIP- SO4.46: 5 residues within 4Å:- Chain C: L.514, R.515, Q.518
- Chain E: R.509
- Ligands: SO4.45
 Ligand excluded by PLIP- SO4.56: 2 residues within 4Å:- Chain D: R.347, Q.351
 Ligand excluded by PLIP- SO4.60: 4 residues within 4Å:- Chain D: Q.316, G.413, N.414, N.415
 Ligand excluded by PLIP- SO4.61: 5 residues within 4Å:- Chain D: W.231, R.242, L.286, S.287, V.288
 Ligand excluded by PLIP- SO4.63: 5 residues within 4Å:- Chain D: K.323, Y.420, R.515
- Chain G: R.509
- Ligands: SO4.64
 Ligand excluded by PLIP- SO4.64: 5 residues within 4Å:- Chain D: L.514, R.515, Q.518
- Chain G: R.509
- Ligands: SO4.63
 Ligand excluded by PLIP- SO4.74: 2 residues within 4Å:- Chain E: R.347, Q.351
 Ligand excluded by PLIP- SO4.78: 4 residues within 4Å:- Chain E: Q.316, G.413, N.414, N.415
 Ligand excluded by PLIP- SO4.79: 5 residues within 4Å:- Chain E: W.231, R.242, L.286, S.287, V.288
 Ligand excluded by PLIP- SO4.81: 5 residues within 4Å:- Chain C: R.509
- Chain E: K.323, Y.420, R.515
- Ligands: SO4.82
 Ligand excluded by PLIP- SO4.82: 5 residues within 4Å:- Chain C: R.509
- Chain E: L.514, R.515, Q.518
- Ligands: SO4.81
 Ligand excluded by PLIP- SO4.92: 2 residues within 4Å:- Chain F: R.347, Q.351
 Ligand excluded by PLIP- SO4.96: 4 residues within 4Å:- Chain F: Q.316, G.413, N.414, N.415
 Ligand excluded by PLIP- SO4.97: 5 residues within 4Å:- Chain F: W.231, R.242, L.286, S.287, V.288
 Ligand excluded by PLIP- SO4.99: 5 residues within 4Å:- Chain B: R.509
- Chain F: K.323, Y.420, R.515
- Ligands: SO4.100
 Ligand excluded by PLIP- SO4.100: 5 residues within 4Å:- Chain B: R.509
- Chain F: L.514, R.515, Q.518
- Ligands: SO4.99
 Ligand excluded by PLIP- SO4.110: 2 residues within 4Å:- Chain G: R.347, Q.351
 Ligand excluded by PLIP- SO4.114: 4 residues within 4Å:- Chain G: Q.316, G.413, N.414, N.415
 Ligand excluded by PLIP- SO4.115: 5 residues within 4Å:- Chain G: W.231, R.242, L.286, S.287, V.288
 Ligand excluded by PLIP- SO4.117: 5 residues within 4Å:- Chain D: R.509
- Chain G: K.323, Y.420, R.515
- Ligands: SO4.118
 Ligand excluded by PLIP- SO4.118: 5 residues within 4Å:- Chain D: R.509
- Chain G: L.514, R.515, Q.518
- Ligands: SO4.117
 Ligand excluded by PLIP- SO4.128: 2 residues within 4Å:- Chain H: R.347, Q.351
 Ligand excluded by PLIP- SO4.132: 4 residues within 4Å:- Chain H: Q.316, G.413, N.414, N.415
 Ligand excluded by PLIP- SO4.133: 5 residues within 4Å:- Chain H: W.231, R.242, L.286, S.287, V.288
 Ligand excluded by PLIP- SO4.135: 5 residues within 4Å:- Chain A: R.509
- Chain H: K.323, Y.420, R.515
- Ligands: SO4.136
 Ligand excluded by PLIP- SO4.136: 5 residues within 4Å:- Chain A: R.509
- Chain H: L.514, R.515, Q.518
- Ligands: SO4.135
 Ligand excluded by PLIP
- 8 x NA: SODIUM ION(Non-functional Binders)
- NA.3: 3 residues within 4Å:- Chain A: F.525
- Chain C: F.521, F.525
 No protein-ligand interaction detected (PLIP)- NA.21: 3 residues within 4Å:- Chain B: F.525
- Chain D: F.521, F.525
 No protein-ligand interaction detected (PLIP)- NA.39: 3 residues within 4Å:- Chain A: F.521, F.525
- Chain C: F.525
 No protein-ligand interaction detected (PLIP)- NA.57: 3 residues within 4Å:- Chain B: F.521, F.525
- Chain D: F.525
 No protein-ligand interaction detected (PLIP)- NA.75: 3 residues within 4Å:- Chain E: F.525
- Chain G: F.521, F.525
 No protein-ligand interaction detected (PLIP)- NA.93: 3 residues within 4Å:- Chain F: F.525
- Chain H: F.521, F.525
 No protein-ligand interaction detected (PLIP)- NA.111: 3 residues within 4Å:- Chain E: F.521, F.525
- Chain G: F.525
 No protein-ligand interaction detected (PLIP)- NA.129: 3 residues within 4Å:- Chain F: F.521, F.525
- Chain H: F.525
 No protein-ligand interaction detected (PLIP)
- 8 x CL: CHLORIDE ION(Non-functional Binders)
- CL.4: 3 residues within 4Å:- Chain A: S.487, T.488, T.508
 Ligand excluded by PLIP- CL.22: 3 residues within 4Å:- Chain B: S.487, T.488, T.508
 Ligand excluded by PLIP- CL.40: 3 residues within 4Å:- Chain C: S.487, T.488, T.508
 Ligand excluded by PLIP- CL.58: 3 residues within 4Å:- Chain D: S.487, T.488, T.508
 Ligand excluded by PLIP- CL.76: 3 residues within 4Å:- Chain E: S.487, T.488, T.508
 Ligand excluded by PLIP- CL.94: 3 residues within 4Å:- Chain F: S.487, T.488, T.508
 Ligand excluded by PLIP- CL.112: 3 residues within 4Å:- Chain G: S.487, T.488, T.508
 Ligand excluded by PLIP- CL.130: 3 residues within 4Å:- Chain H: S.487, T.488, T.508
 Ligand excluded by PLIP
- 8 x GOL: GLYCEROL(Non-functional Binders)
- GOL.5: 6 residues within 4Å:- Chain A: M.16, L.18, Y.61, W.98, D.129, K.131
 2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:W.98, A:K.131
 - GOL.23: 6 residues within 4Å:- Chain B: M.16, L.18, Y.61, W.98, D.129, K.131
 2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:W.98, B:K.131
 - GOL.41: 6 residues within 4Å:- Chain C: M.16, L.18, Y.61, W.98, D.129, K.131
 2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:W.98, C:K.131
 - GOL.59: 6 residues within 4Å:- Chain D: M.16, L.18, Y.61, W.98, D.129, K.131
 2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:W.98, D:K.131
 - GOL.77: 6 residues within 4Å:- Chain E: M.16, L.18, Y.61, W.98, D.129, K.131
 2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:W.98, E:K.131
 - GOL.95: 6 residues within 4Å:- Chain F: M.16, L.18, Y.61, W.98, D.129, K.131
 2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:W.98, F:K.131
 - GOL.113: 6 residues within 4Å:- Chain G: M.16, L.18, Y.61, W.98, D.129, K.131
 2 PLIP interactions:2 interactions with chain G- Hydrogen bonds: G:W.98, G:K.131
 - GOL.131: 6 residues within 4Å:- Chain H: M.16, L.18, Y.61, W.98, D.129, K.131
 2 PLIP interactions:2 interactions with chain H- Hydrogen bonds: H:W.98, H:K.131
 
- 56 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)(Non-covalent)
- NAG.8: 1 residues within 4Å:- Ligands: NAG-FUC.1
 Ligand excluded by PLIP- NAG.11: 4 residues within 4Å:- Chain A: N.106, N.188, K.190
- Ligands: FUC.12
 Ligand excluded by PLIP- NAG.13: 2 residues within 4Å:- Chain A: R.14, N.57
 Ligand excluded by PLIP- NAG.14: 4 residues within 4Å:- Chain A: R.465, K.469, E.482, N.485
 Ligand excluded by PLIP- NAG.15: 2 residues within 4Å:- Chain A: N.256, T.258
 Ligand excluded by PLIP- NAG.16: 4 residues within 4Å:- Chain A: Y.237, N.241, N.245
- Ligands: NAG.17
 Ligand excluded by PLIP- NAG.17: 3 residues within 4Å:- Chain A: K.248
- Ligands: NAG.16, FUC.18
 Ligand excluded by PLIP- NAG.26: 1 residues within 4Å:- Ligands: NAG-FUC.19
 Ligand excluded by PLIP- NAG.29: 4 residues within 4Å:- Chain B: N.106, N.188, K.190
- Ligands: FUC.30
 Ligand excluded by PLIP- NAG.31: 2 residues within 4Å:- Chain B: R.14, N.57
 Ligand excluded by PLIP- NAG.32: 4 residues within 4Å:- Chain B: R.465, K.469, E.482, N.485
 Ligand excluded by PLIP- NAG.33: 2 residues within 4Å:- Chain B: N.256, T.258
 Ligand excluded by PLIP- NAG.34: 4 residues within 4Å:- Chain B: Y.237, N.241, N.245
- Ligands: NAG.35
 Ligand excluded by PLIP- NAG.35: 3 residues within 4Å:- Chain B: K.248
- Ligands: NAG.34, FUC.36
 Ligand excluded by PLIP- NAG.44: 1 residues within 4Å:- Ligands: NAG-FUC.37
 Ligand excluded by PLIP- NAG.47: 4 residues within 4Å:- Chain C: N.106, N.188, K.190
- Ligands: FUC.48
 Ligand excluded by PLIP- NAG.49: 2 residues within 4Å:- Chain C: R.14, N.57
 Ligand excluded by PLIP- NAG.50: 4 residues within 4Å:- Chain C: R.465, K.469, E.482, N.485
 Ligand excluded by PLIP- NAG.51: 2 residues within 4Å:- Chain C: N.256, T.258
 Ligand excluded by PLIP- NAG.52: 4 residues within 4Å:- Chain C: Y.237, N.241, N.245
- Ligands: NAG.53
 Ligand excluded by PLIP- NAG.53: 3 residues within 4Å:- Chain C: K.248
- Ligands: NAG.52, FUC.54
 Ligand excluded by PLIP- NAG.62: 1 residues within 4Å:- Ligands: NAG-FUC.55
 Ligand excluded by PLIP- NAG.65: 4 residues within 4Å:- Chain D: N.106, N.188, K.190
- Ligands: FUC.66
 Ligand excluded by PLIP- NAG.67: 2 residues within 4Å:- Chain D: R.14, N.57
 Ligand excluded by PLIP- NAG.68: 4 residues within 4Å:- Chain D: R.465, K.469, E.482, N.485
 Ligand excluded by PLIP- NAG.69: 2 residues within 4Å:- Chain D: N.256, T.258
 Ligand excluded by PLIP- NAG.70: 4 residues within 4Å:- Chain D: Y.237, N.241, N.245
- Ligands: NAG.71
 Ligand excluded by PLIP- NAG.71: 3 residues within 4Å:- Chain D: K.248
- Ligands: NAG.70, FUC.72
 Ligand excluded by PLIP- NAG.80: 1 residues within 4Å:- Ligands: NAG-FUC.73
 Ligand excluded by PLIP- NAG.83: 4 residues within 4Å:- Chain E: N.106, N.188, K.190
- Ligands: FUC.84
 Ligand excluded by PLIP- NAG.85: 2 residues within 4Å:- Chain E: R.14, N.57
 Ligand excluded by PLIP- NAG.86: 4 residues within 4Å:- Chain E: R.465, K.469, E.482, N.485
 Ligand excluded by PLIP- NAG.87: 2 residues within 4Å:- Chain E: N.256, T.258
 Ligand excluded by PLIP- NAG.88: 4 residues within 4Å:- Chain E: Y.237, N.241, N.245
- Ligands: NAG.89
 Ligand excluded by PLIP- NAG.89: 3 residues within 4Å:- Chain E: K.248
- Ligands: NAG.88, FUC.90
 Ligand excluded by PLIP- NAG.98: 1 residues within 4Å:- Ligands: NAG-FUC.91
 Ligand excluded by PLIP- NAG.101: 4 residues within 4Å:- Chain F: N.106, N.188, K.190
- Ligands: FUC.102
 Ligand excluded by PLIP- NAG.103: 2 residues within 4Å:- Chain F: R.14, N.57
 Ligand excluded by PLIP- NAG.104: 4 residues within 4Å:- Chain F: R.465, K.469, E.482, N.485
 Ligand excluded by PLIP- NAG.105: 2 residues within 4Å:- Chain F: N.256, T.258
 Ligand excluded by PLIP- NAG.106: 4 residues within 4Å:- Chain F: Y.237, N.241, N.245
- Ligands: NAG.107
 Ligand excluded by PLIP- NAG.107: 3 residues within 4Å:- Chain F: K.248
- Ligands: NAG.106, FUC.108
 Ligand excluded by PLIP- NAG.116: 1 residues within 4Å:- Ligands: NAG-FUC.109
 Ligand excluded by PLIP- NAG.119: 4 residues within 4Å:- Chain G: N.106, N.188, K.190
- Ligands: FUC.120
 Ligand excluded by PLIP- NAG.121: 2 residues within 4Å:- Chain G: R.14, N.57
 Ligand excluded by PLIP- NAG.122: 4 residues within 4Å:- Chain G: R.465, K.469, E.482, N.485
 Ligand excluded by PLIP- NAG.123: 2 residues within 4Å:- Chain G: N.256, T.258
 Ligand excluded by PLIP- NAG.124: 4 residues within 4Å:- Chain G: Y.237, N.241, N.245
- Ligands: NAG.125
 Ligand excluded by PLIP- NAG.125: 3 residues within 4Å:- Chain G: K.248
- Ligands: NAG.124, FUC.126
 Ligand excluded by PLIP- NAG.134: 1 residues within 4Å:- Ligands: NAG-FUC.127
 Ligand excluded by PLIP- NAG.137: 4 residues within 4Å:- Chain H: N.106, N.188, K.190
- Ligands: FUC.138
 Ligand excluded by PLIP- NAG.139: 2 residues within 4Å:- Chain H: R.14, N.57
 Ligand excluded by PLIP- NAG.140: 4 residues within 4Å:- Chain H: R.465, K.469, E.482, N.485
 Ligand excluded by PLIP- NAG.141: 2 residues within 4Å:- Chain H: N.256, T.258
 Ligand excluded by PLIP- NAG.142: 4 residues within 4Å:- Chain H: Y.237, N.241, N.245
- Ligands: NAG.143
 Ligand excluded by PLIP- NAG.143: 3 residues within 4Å:- Chain H: K.248
- Ligands: NAG.142, FUC.144
 Ligand excluded by PLIP
- 16 x FUC: alpha-L-fucopyranose(Non-covalent)
- FUC.12: 6 residues within 4Å:- Chain A: N.188, K.190, S.191, R.219, K.476
- Ligands: NAG.11
 6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:N.188, A:S.191, A:R.219
- Water bridges: A:T.108, A:S.191, A:S.191
 - FUC.18: 5 residues within 4Å:- Chain A: N.245, K.248, F.278, V.280
- Ligands: NAG.17
 3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:N.245
- Hydrogen bonds: A:K.248, A:F.278
 - FUC.30: 6 residues within 4Å:- Chain B: N.188, K.190, S.191, R.219, K.476
- Ligands: NAG.29
 5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:N.188, B:S.191, B:R.219
- Water bridges: B:S.191, B:S.191
 - FUC.36: 5 residues within 4Å:- Chain B: N.245, K.248, F.278, V.280
- Ligands: NAG.35
 3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:N.245
- Hydrogen bonds: B:K.248, B:F.278
 - FUC.48: 6 residues within 4Å:- Chain C: N.188, K.190, S.191, R.219, K.476
- Ligands: NAG.47
 5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:N.188, C:S.191, C:R.219
- Water bridges: C:S.191, C:S.191
 - FUC.54: 5 residues within 4Å:- Chain C: N.245, K.248, F.278, V.280
- Ligands: NAG.53
 3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:N.245
- Hydrogen bonds: C:K.248, C:F.278
 - FUC.66: 6 residues within 4Å:- Chain D: N.188, K.190, S.191, R.219, K.476
- Ligands: NAG.65
 6 PLIP interactions:6 interactions with chain D- Hydrogen bonds: D:N.188, D:S.191, D:R.219
- Water bridges: D:T.108, D:S.191, D:S.191
 - FUC.72: 5 residues within 4Å:- Chain D: N.245, K.248, F.278, V.280
- Ligands: NAG.71
 3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:N.245
- Hydrogen bonds: D:K.248, D:F.278
 - FUC.84: 6 residues within 4Å:- Chain E: N.188, K.190, S.191, R.219, K.476
- Ligands: NAG.83
 6 PLIP interactions:6 interactions with chain E- Hydrogen bonds: E:N.188, E:S.191, E:R.219
- Water bridges: E:T.108, E:S.191, E:S.191
 - FUC.90: 5 residues within 4Å:- Chain E: N.245, K.248, F.278, V.280
- Ligands: NAG.89
 3 PLIP interactions:3 interactions with chain E- Hydrophobic interactions: E:N.245
- Hydrogen bonds: E:K.248, E:F.278
 - FUC.102: 6 residues within 4Å:- Chain F: N.188, K.190, S.191, R.219, K.476
- Ligands: NAG.101
 6 PLIP interactions:6 interactions with chain F- Hydrogen bonds: F:N.188, F:S.191, F:R.219
- Water bridges: F:T.108, F:S.191, F:S.191
 - FUC.108: 5 residues within 4Å:- Chain F: N.245, K.248, F.278, V.280
- Ligands: NAG.107
 3 PLIP interactions:3 interactions with chain F- Hydrophobic interactions: F:N.245
- Hydrogen bonds: F:K.248, F:F.278
 - FUC.120: 6 residues within 4Å:- Chain G: N.188, K.190, S.191, R.219, K.476
- Ligands: NAG.119
 5 PLIP interactions:5 interactions with chain G- Hydrogen bonds: G:N.188, G:S.191, G:R.219
- Water bridges: G:S.191, G:S.191
 - FUC.126: 5 residues within 4Å:- Chain G: N.245, K.248, F.278, V.280
- Ligands: NAG.125
 3 PLIP interactions:3 interactions with chain G- Hydrophobic interactions: G:N.245
- Hydrogen bonds: G:K.248, G:F.278
 - FUC.138: 6 residues within 4Å:- Chain H: N.188, K.190, S.191, R.219, K.476
- Ligands: NAG.137
 5 PLIP interactions:5 interactions with chain H- Hydrogen bonds: H:N.188, H:S.191, H:R.219
- Water bridges: H:S.191, H:S.191
 - FUC.144: 5 residues within 4Å:- Chain H: N.245, K.248, F.278, V.280
- Ligands: NAG.143
 3 PLIP interactions:3 interactions with chain H- Hydrophobic interactions: H:N.245
- Hydrogen bonds: H:K.248, H:F.278
 
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Carletti, E. et al., Reaction of Cresyl Saligenin Phosphate, the Organophosphorus Agent Implicated in Aerotoxic Syndrome, with Human Cholinesterases: Mechanistic Studies Employing Kinetics, Mass Spectrometry, and X-Ray Structure Analysis. Chem.Res.Toxicol. (2011)
            
- Release Date
- 2011-06-29
- Peptides
- CHOLINESTERASE: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
 PDB Chain Id:A
 AB
 AC
 AD
 AE
 AF
 AG
 AH
 A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-octamer
- Ligands
- 8 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 40 x SO4: SULFATE ION(Non-functional Binders)
- 8 x NA: SODIUM ION(Non-functional Binders)
- 8 x CL: CHLORIDE ION(Non-functional Binders)
- 8 x GOL: GLYCEROL(Non-functional Binders)
- 56 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)(Non-covalent)
- 16 x FUC: alpha-L-fucopyranose(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Carletti, E. et al., Reaction of Cresyl Saligenin Phosphate, the Organophosphorus Agent Implicated in Aerotoxic Syndrome, with Human Cholinesterases: Mechanistic Studies Employing Kinetics, Mass Spectrometry, and X-Ray Structure Analysis. Chem.Res.Toxicol. (2011)
            
- Release Date
- 2011-06-29
- Peptides
- CHOLINESTERASE: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
 PDB Chain Id:A
 AB
 AC
 AD
 AE
 AF
 AG
 AH
 A